We found that ATAC suppressed the age-dependent increase in MAC formation and caspase-1 cleavage (a prominent indicator for NLRP3 inflammasome activation) in RPE/choroid tissue homogenates, which implies potential benefits by targeting MAC formation in AMD pathogenesis (Figure 2). The gene discussed is NLRP3; the disease is age-related macular degeneration.